Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 172, Issue 5, Pages 1237-1249
Publisher
Wiley
Online
2014-11-03
DOI
10.1111/bph.12999
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl
- (2014) Melanie P. Chin et al. AMERICAN JOURNAL OF NEPHROLOGY
- Nrf2 signaling modulates cigarette smoke-induced complement activation in retinal pigmented epithelial cells
- (2014) Lei Wang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Antioxidant Drug Therapy Approaches for Neuroprotection in Chronic Diseases of the Retina
- (2014) Andrew Payne et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lipopolysaccharide-Induced Expression of NAD(P)H:Quinone Oxidoreductase 1 and Heme Oxygenase-1 Protects against Excessive Inflammatory Responses in Human Monocytes
- (2014) S. A. Rushworth et al. JOURNAL OF IMMUNOLOGY
- Topical Application of the Synthetic Triterpenoid RTA 408 Protects Mice from Radiation-Induced Dermatitis
- (2014) Scott A. Reisman et al. RADIATION RESEARCH
- The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Relationship of Glycated Albumin to Blood Glucose and HbA1c Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study
- (2013) D. M. Nathan et al. DIABETES
- NRF2 plays a protective role in diabetic retinopathy in mice
- (2013) Zhenhua Xu et al. DIABETOLOGIA
- Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
- (2013) K Ghasemi Falavarjani et al. EYE
- Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration
- (2013) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Synthetic oleanane triterpenoids: magic bullets or not?
- (2013) Hanna E. Abboud KIDNEY INTERNATIONAL
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
- (2013) Adam J. Pawson et al. NUCLEIC ACIDS RESEARCH
- Toward clinical application of the Keap1–Nrf2 pathway
- (2013) Takafumi Suzuki et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Antioxidant Therapy: Current Status and Future Prospects
- (2012) O. Firuzi et al. CURRENT MEDICINAL CHEMISTRY
- Intraocular corticosteroids for posterior segment disease: 2012 update
- (2012) Daniel F Kiernan et al. EXPERT OPINION ON PHARMACOTHERAPY
- Vitamin A Supplementation Improves Retinal Function in Infants at Risk of Retinopathy of Prematurity
- (2012) Helen Mactier et al. JOURNAL OF PEDIATRICS
- Consequences of oxidative stress in age-related macular degeneration
- (2012) Stuart G. Jarrett et al. MOLECULAR ASPECTS OF MEDICINE
- New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative Stress
- (2011) Michael B. Sporn et al. JOURNAL OF NATURAL PRODUCTS
- Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
- (2011) Pablo E. Pergola et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discovery of the Negative Regulator of Nrf2, Keap1: A Historical Overview
- (2010) Ken Itoh et al. ANTIOXIDANTS & REDOX SIGNALING
- Guidelines for reporting experiments involving animals: the ARRIVE guidelines
- (2010) JC McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Biodegradable Intraocular Therapies for Retinal Disorders
- (2010) Noriyuki Kuno et al. DRUGS & AGING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started